VolitionRX VNRX 深 沪
等待开盘 08-25 09:30:00 美东时间
0.391
-0.026
-6.21%
华盛通- 最 高0.43
- 今 开0.43
- 成交量 113.24万股
- 最 低 0.3738
- 昨 收 0.4169
- 总市值 533.69万
- 52周最高 14.80
- 市盈率 静 --
- 换手率 8.30%
- 52周最低 0.3738
- 委 比 0.00%
- 总股本 1364.94万
- 历史最高 185.60
- 量 比 1.88
- 振 幅 13.48%
- 历史最低 0.3738
- 每 手 1
- 风险率 3.75%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多VolitionRX Q2 EPS $(0.85) Misses $(0.57) Estimate, Sales $398.657K Miss $482.667K Estimate
VolitionRX (AMEX:VNRX) reported quarterly losses of $(0.85) per share which missed the analyst consensus estimate of $(0.57) by 49.12 percent. This is a 1316.67 percent decrease over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $398.657 thousand...
08-14 04:42
VolitionRx Issues Shares to Settle Convertible Note Obligations
VolitionRX ( ($VNRX) ) just unveiled an update. VolitionRx Limited disclosed th...
08-08 05:32
Volition Advances Nu.Q® NETs Platform Towards Commercialization
Consistent international data positions Nu.Q® H3.1 as a potential "game changer" in sepsis management within a $3.8 billion addressable market HENDERSON, Nev., July 30, 2026 /PRNewswire/ -- ...
07-30 20:17
VolitionRx Shareholders Approve Governance and Capital Changes
VolitionRX ( ($VNRX) ) has provided an update. On July 17, 2026, VolitionRx hel...
07-22 04:57
VolitionRx Partners With Sysmex To Streamline Volition's Nu.Q NETs H3.1 Assay
VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, announces a collaboration with Sysmex (TYO:6869), a leader in global in vitro diagnostics, to optimize Volition's Nu.Q® NETs H3.1 assay on the Sysmex platform.
06-17 20:16
VolitionRx Announces Pricing of $4.6 Million Public Offering
$4.6 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the full exercise of warrants HENDERSON, Nev., June 7, 2026 /PRNewswire/ -- VolitionRx L...
06-08 06:30
U.S. State Dept Announces Nearly $38M In Additional Funding Toward The Department's Ongoing Ebola Response Efforts
https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/
06-06 02:24
